Wanted Dead or Alive: Delhi High Court Holds Patent Revocation Survives Expiry and Section 107 Defence

Hand wearing a blue glove holding a small vial beside torn paper with the words “How to Survive,” symbolizing the Patent revocation case as decided by the Delhi High Court between Boehringer Ingelheim v. Controller Featured image for article: Wanted Dead or Alive: Delhi High Court Holds Patent Revocation Survives Expiry and Section 107 Defence

In the case of Boehringer Ingelheim Pharma GmbH & Co. KG v. Controller of Patents & Anr., the Delhi High Court addressed two important questions under the Patents Act: whether a revocation petition survives patent expiry, and whether it can continue after a Section 107 invalidity defence is raised in an infringement suit. The dispute arose from parallel revocation and infringement proceedings relating to Patent IN 243301 covering Linagliptin. The court held that revocation under Section 64 remains maintainable despite patent expiry and is not barred by a Section 107 defence.

Read more about Wanted Dead or Alive: Delhi High Court Holds Patent Revocation Survives Expiry and Section 107 Defence

Revocation is Distinct from Invalidity Defence and Survives Patent Expiry, rules Delhi High Court

Gavel, law books, and justice scale beside the text "Revocation Is Distinct from Invalidity Defence and Survives Patent Expiry, Rules Delhi High Court" on a dark blue background. Featured image for article: Revocation is Distinct from Invalidity Defence and Survives Patent Expiry, rules Delhi High Court

The Delhi High Court held that a revocation petition under Section 64 of the Patents Act is distinct from an invalidity defence under Section 107 and remains valid post-patent expiry. The Court emphasized the broader legal impact of revocation, affirming its maintainability even when the patent has lapsed.

Read more about Revocation is Distinct from Invalidity Defence and Survives Patent Expiry, rules Delhi High Court

Madras High Court Upholds Patent Validity in Embio Limited vs. Malladi Drugs & Pharmaceuticals

The Madras High Court affirmed the validity of Malladi Drugs’ patent for chiral beta-amino alcohols, highlighting the invention’s novelty and inventive step. The judgment clarifies key principles on patent revocation and the definition of a “person interested” under Indian patent law.

Read more about Madras High Court Upholds Patent Validity in Embio Limited vs. Malladi Drugs & Pharmaceuticals

Justice Pratibha Singh clarifies the jurisdiction of High Courts over Patent Revocations and Appeals

Justice Pratibha Singh has clarified the jurisdiction of High Courts regarding patent appeals, revocations, and writ petitions. Her judgment in Dr. Reddys Laboratories Limited vs. The Controller of Patents & Ors. provides structured guidance on the appropriate forums for each type of patent proceeding under Indian law.

Read more about Justice Pratibha Singh clarifies the jurisdiction of High Courts over Patent Revocations and Appeals

Vitiation of IPAB and Beyond – Changes to the Indian Patents Act

The abolition of the IPAB has shifted appellate and adjudicatory functions under the Indian Patents Act to the High Courts. This post analyses the significant legal changes, outlining the expanded role of Indian High Courts in patent matters after the Tribunals Reforms Ordinance 2021.

Read more about Vitiation of IPAB and Beyond – Changes to the Indian Patents Act